KYNB
KYNTRA BIO, INC.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$5.28
+8.87%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-27.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 6, 2026 | Singer Andrew E. · director | A-Award | 14,000 | $6.50 |
| Sep 9, 2026 | Wettig Thane · director, officer: CEO | F-InKind | 209 | $8.55 |
| Sep 9, 2026 | DeLucia David · officer: Chief Financial Officer | F-InKind | 22 | $8.55 |
| Jun 17, 2026 | Ho Maykin · director | A-Award | 7,000 | $7.13 |
| Jun 17, 2026 | EDWARDS JEFFREY L · director | A-Award | 7,000 | $7.13 |
| Jun 17, 2026 | Kauffman Michael · director | A-Award | 7,000 | $7.13 |
| Jun 17, 2026 | Schoeneck James A · director | A-Award | 7,000 | $7.13 |
| Jun 9, 2026 | Wettig Thane · director, officer: CEO | F-InKind | 198 | $6.71 |
| Jun 9, 2026 | DeLucia David · officer: Chief Financial Officer | F-InKind | 52 | $6.71 |
| May 19, 2026 | Wettig Thane · director, officer: CEO | Purchase | 2,800 | $7.09 |
| May 18, 2026 | Wettig Thane · director, officer: CEO | Purchase | 2,800 | $7.09 |
| Mar 10, 2026 | DeLucia David · officer: Chief Financial Officer | F-InKind | 60 | $6.84 |
| Mar 10, 2026 | Wettig Thane · director, officer: CEO | F-InKind | 277 | $6.84 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 6, 2026